SMS Pharma rises 12% on USFDA nod for Andhra Pradesh plant

SMS Pharma rises 12% on USFDA nod for Andhra Pradesh plant

Shares of SMS Pharmaceuticals  climbed 11.8 percent in early trade Monday on getting approval from the US health regulator for one of its unit in Andhra Pradesh. “SMS has received approval from the US Food and Drug Administration (USFDA) for manufacturing facility (unit 7) located at Kandivalasa village, Pusapatirega Mandal, Vizianagaram distict, Andhra Pradesh,” says the Telangana-based pharma company in its filing. The US health regulator had conducted inspection of this plant in third week of April.

Read more at: http://www.moneycontrol.com/news/buzzing-stocks/sms-pharma-rises-12usfda-nod-for-andhra-pradesh-plant_4754061.html?utm_source=ref_article